Home » Topics » Disease categories and therapies » Inflammatory

Inflammatory
RSS

Omeros selects clinical candidate for MASP-2 antibody program

May 14, 2010

Osiris achieves milestone for remestemcel-L development progress in Japan

April 29, 2010

DMC recommends continued enrollment in eritoran phase III trial for severe sepsis

March 26, 2010

Phase I trial of deferoxamine in acute cerebral hemorrhage currently recruiting participants

March 12, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...